Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combined analysis of gut microbiome and serum metabolomics reveals novel biomarkers in patients with early-stage non-small cell lung cancer
Boxiong Ni, Xianglong Kong, Yubo Yan, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 25

Showing 25 citing articles:

Gut microbiome affects the response to immunotherapy in non‐small cell lung cancer
Shengnan Ren, Lingxin Feng, Haoran Liu, et al.
Thoracic Cancer (2024) Vol. 15, Iss. 14, pp. 1149-1163
Open Access | Times Cited: 17
Gut microbial metabolites in lung cancer development and immunotherapy: Novel insights into gut-lung axis
Xinpei Li, Shijie Shang, Meng Wu, et al.
Cancer Letters (2024) Vol. 598, pp. 217096-217096
Closed Access | Times Cited: 11
Targeted metabolomic profiling as a tool for diagnostics of patients with non-small-cell lung cancer
Ksenia M. Shestakova, Natalia E. Moskaleva, Andrey A. Boldin, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 11
A new perspective on gut-lung axis affected through resident microbiome and their implications on immune response in respiratory diseases
Cong Xu, Mengqi Hao, Xiaohu Zai, et al.
Archives of Microbiology (2024) Vol. 206, Iss. 3
Closed Access | Times Cited: 4
Alterations of gut microbiota and its metabolomics in children with 6PPDQ, PBDE, PCB, and metal(loid) exposure
Zhuxia Zhang, Qi Zhong, Ziyi Qian, et al.
Journal of Hazardous Materials (2024) Vol. 475, pp. 134862-134862
Closed Access | Times Cited: 4
Unravelling the prognostic and operative role of intratumoural microbiota in non‐small cell lung cancer: Insights from 16S rRNA and RNA sequencing
Fuling Mao, Zixuan Hu, Ruifeng Shi, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 1
Open Access
Farfarae Flos Mitigates Cigarette Smoking‐Induced Lung Inflammation by Regulating the Lysophosphatidylcholine Biosynthesis and Tryptophan Metabolism
Aoxue Liu, S Li, Xianlong Dong, et al.
Biomedical Chromatography (2025) Vol. 39, Iss. 2
Closed Access
Metabolomics for early-stage lung adenocarcinoma: diagnostic biomarker screening
Danxiong Sun, Yanhong Du, Rufang Li, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Machine learning-derived diagnostic model of epithelial ovarian cancer based on gut microbiome signatures
Cheng Chen, Chengyuan Deng, Yanwen Li, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Mechanistic study of Lonicerae Japonicae Flos (Caprifoliaceae) in non-small cell lung cancer prevention and treatment through integrative pharmacology, multi-machine learning, artificial intelligence, and in vitro experiments
Can Liu, Peng He, Rui Qiao, et al.
Journal of Ethnopharmacology (2025), pp. 119832-119832
Open Access
Integrative multi-omics analysis of the microbiome and metabolome in bronchoalveolar lavage fluid from patients with early-stage lung cancer
Jiajun Xie, Nengyang Zhu, Weiguo Xu
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Gut–lung axis: role of the gut microbiota in non-small cell lung cancer immunotherapy
Huaiyuan Zhang, Ziyuan Xu
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 9
Gut Microbiota Signatures with Potential Clinical Usefulness in Colorectal and Non-small Cell Lung Cancers
Sofía Tesolato, Juan Vicente-Valor, Mateo Paz-Cabezas, et al.
(2024)
Open Access | Times Cited: 2
The implication of microbiome in lungs cancer: mechanisms and strategies of cancer growth, diagnosis and therapy
Yasmin Bano, Abhinav Shrivastava, Piyush Kumar Shukla, et al.
Critical Reviews in Microbiology (2024), pp. 1-25
Closed Access | Times Cited: 2
Changes in Intestinal Flora and Serum Metabolites Pre- and Post-Antitumor Drug Therapy in Patients with Non-Small Cell Lung Cancer
Zhenyu Tian, Yan’e Liu, Dan Zhu, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 529-529
Open Access | Times Cited: 1
Developing technologies and areas of interest in lung cancer screening adjuncts
Ju Ae Park, Duy Pham, Sriya Yalamanchili, et al.
Journal of Thoracic Disease (2024) Vol. 16, Iss. 2, pp. 1552-1564
Open Access | Times Cited: 1
Gut Microbiota Signatures with Potential Clinical Usefulness in Colorectal and Non-Small Cell Lung Cancers
Sofía Tesolato, Juan Vicente-Valor, Mateo Paz-Cabezas, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 703-703
Open Access | Times Cited: 1
Microbes for lung cancer detection: feasibility and limitations
Sirui Zhou, Weijian Zhu, Hehua Guo, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Gut microbiota and metabolites associated with immunotherapy efficacy in extensive-stage small cell lung cancer: a pilot study
Li‐Yang Sun, Xueting Wang, Huimin Zhou, et al.
Journal of Thoracic Disease (2024) Vol. 16, Iss. 10, pp. 6936-6954
Open Access | Times Cited: 1
Crotonis Fructus-induced gut microbiota and serum metabolic disorders in rats
Jiali Wang, Ze-Fei Jia, Wen Pan, et al.
Applied Microbiology and Biotechnology (2023) Vol. 107, Iss. 22, pp. 6949-6962
Closed Access | Times Cited: 3
Dysbiosis of Blood and Intestinal Microbiomes in Patients with Lung Cancer
Xinbo Zhang, Feng Zhao, Yani Chen, et al.
(2024)
Closed Access
Dynamic mutation late acceptance hill climbing aided red fox optimization for metabolomic biomarkers selection from lung cancer patient sera
Shuli Guo, Zhilei Zhao, Lina Han, et al.
Applied Soft Computing (2024) Vol. 159, pp. 111602-111602
Closed Access
Alterations of Ceramides, Acylcarnitines, GlyceroLPLs, and Amines in NSCLC Tissues
Jie Zhang, Xiaoling Zang, Peng Jiao, et al.
Journal of Proteome Research (2024)
Closed Access
Multi-omics research progress in lung cancer

New medicine. (2024), pp. 1-9
Closed Access
Targeted metabolomic profiling as a tool for diagnostics of patients with non- small-cell lung cancer
Ksenia M. Shestakova, Natalia E. Moskaleva, Andrey A. Boldin, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Page 1

Scroll to top